On September 28, 2023, Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. closed the transaction. The company announced that it has completed the change registration procedures, and obtained a new "Business License". The registered capital of the company is CNY 80 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.03 CNY | +0.13% |
|
-9.71% | -39.33% |
Jun. 18 | JZJ Chain Drugstore Sets Up 10 Million Yuan Subsidiary | MT |
Jun. 11 | JZJ Chain Drugstore Completes Acquisition of Tangren Pharmaceutical | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.33% | 639M | |
-40.15% | 9.56B | |
-17.45% | 7.21B | |
-12.94% | 5.68B | |
-18.93% | 4.52B | |
-3.21% | 4.57B | |
+4.63% | 4.52B | |
+73.68% | 4.6B | |
-19.32% | 2.58B | |
-10.94% | 2.55B |
- Stock Market
- Equities
- 605266 Stock
- News Jianzhijia Pharmaceutical Chain Group Co., Ltd.
- Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. announced that it has received CNY 50 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd.